POXEL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4525 EUR | +1.23% |
|
-0.22% | -14.53% |
| 04-11 | Poxel: CDC falls below the 10% threshold | CF |
| 02-15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 25.41M | - | - | - | - | - | |
| 122B | ||||||
| 112B | ||||||
| 19.33B | - | |||||
| 16.17B | ||||||
| 15.6B | - |
- Stock Market
- Equities
- POXEL Stock
- 7PO Stock
- Charts Poxel
- Sector Chart
